These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

913 related articles for article (PubMed ID: 8027577)

  • 21. Immunopathogenesis of mycosis fungoides/Sézary syndrome (cutaneous T-cell lymphoma).
    Wong HK
    G Ital Dermatol Venereol; 2008 Dec; 143(6):375-83. PubMed ID: 19169210
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased interleukin-36γ expression in skin and sera of patients with atopic dermatitis and mycosis fungoides/Sézary syndrome.
    Otobe S; Sugaya M; Nakajima R; Oka T; Takahashi N; Kabasawa M; Miyagaki T; Asano Y; Sato S
    J Dermatol; 2018 Apr; 45(4):468-471. PubMed ID: 29314201
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinicopathological differential diagnosis of mycosis fungoides/Sézary syndrome from the cutaneous type of adult T-cell leukemia/lymphoma].
    Johno M; Ono T
    Nihon Rinsho; 2000 Mar; 58(3):660-4. PubMed ID: 10741142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Normal and cancer fibroblasts differentially regulate TWIST1, TOX and cytokine gene expression in cutaneous T-cell lymphoma.
    Mehdi SJ; Moerman-Herzog A; Wong HK
    BMC Cancer; 2021 May; 21(1):492. PubMed ID: 33941102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Depressed IL-12-mediated signal transduction in T cells from patients with Sézary syndrome is associated with the absence of IL-12 receptor beta 2 mRNA and highly reduced levels of STAT4.
    Showe LC; Fox FE; Williams D; Au K; Niu Z; Rook AH
    J Immunol; 1999 Oct; 163(7):4073-9. PubMed ID: 10491012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytokine gene profile in circulating blood mononuclear cells from patients with systemic lupus erythematosus: increased interleukin-2 but not interleukin-4 mRNA.
    Horwitz DA; Wang H; Gray JD
    Lupus; 1994 Oct; 3(5):423-8. PubMed ID: 7841998
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Mycosis fungoides and Sézary syndrome : a systematic review].
    André F; Guenova E; Blanchard G
    Rev Med Suisse; 2022 Mar; 18(775):578-589. PubMed ID: 35353453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mycosis fungoides and Sézary's syndrome show distinct histomorphological features.
    Imai S; Burg G; Braun-Falco O
    Dermatologica; 1986; 173(3):131-5. PubMed ID: 3770259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Demonstration of a subpopulation of Ia+ T-helper cells in mycosis fungoides and the Sézary syndrome.
    Hofman FM; Meyer PR; Yanagihara E; Modlin RL; Rea TH; Parker JW; Lukes RJ; Taylor CR
    Am J Dermatopathol; 1983 Apr; 5(2):135-43. PubMed ID: 6224436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor microenvironment in mycosis fungoides and Sézary syndrome.
    Rubio Gonzalez B; Zain J; Rosen ST; Querfeld C
    Curr Opin Oncol; 2016 Jan; 28(1):88-96. PubMed ID: 26632770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expression of T-follicular helper markers in sequential biopsies of progressive mycosis fungoides and other primary cutaneous T-cell lymphomas.
    Bosisio FM; Cerroni L
    Am J Dermatopathol; 2015 Feb; 37(2):115-21. PubMed ID: 25406852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Primary cutaneous peripheral T-cell lymphomas with a T-follicular helper phenotype: an integrative clinical, pathological and molecular case series study.
    Wang L; Rocas D; Dalle S; Sako N; Pelletier L; Martin N; Dupuy A; Tazi N; Balme B; Vergier B; Beylot-Barry M; Carlotti A; Bagot M; Battistella M; Chaby G; Ingen-Housz-Oro S; Gaulard P; Ortonne N
    Br J Dermatol; 2022 Dec; 187(6):970-980. PubMed ID: 35895386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Various cytokines modulate ICAM-1 shedding on melanoma- and CTCL-derived cell lines: inverse regulation of ICAM-1 shedding in a Sézary cell line by interferon-gamma.
    Dummer R; Sigg-Zemann S; Kalthof K; Muletta S; Meyer JC; Burg G
    Dermatology; 1994; 189(2):120-4. PubMed ID: 7915555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T cell subset heterogeneity in a series of patients with mycosis fungoides and Sézary syndrome.
    Piepkorn M; Marty J; Kjeldsberg CR
    J Am Acad Dermatol; 1984 Sep; 11(3):427-32. PubMed ID: 6237132
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential expression of programmed death-1 (PD-1) in Sézary syndrome and mycosis fungoides.
    Cetinözman F; Jansen PM; Vermeer MH; Willemze R
    Arch Dermatol; 2012 Dec; 148(12):1379-85. PubMed ID: 23247480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mycosis fungoides and the Sézary syndrome.
    Kim YH; Hoppe RT
    Semin Oncol; 1999 Jun; 26(3):276-89. PubMed ID: 10375085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diminished CD3 expression is useful for detecting and enumerating Sézary cells.
    Edelman J; Meyerson HJ
    Am J Clin Pathol; 2000 Sep; 114(3):467-77. PubMed ID: 10989648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. STAT3-mediated constitutive expression of SOCS-3 in cutaneous T-cell lymphoma.
    Brender C; Nielsen M; Kaltoft K; Mikkelsen G; Zhang Q; Wasik M; Billestrup N; Odum N
    Blood; 2001 Feb; 97(4):1056-62. PubMed ID: 11159537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complete molecular remission during biologic response modifier therapy for Sézary syndrome is associated with enhanced helper T type 1 cytokine production and natural killer cell activity.
    Yoo EK; Cassin M; Lessin SR; Rook AH
    J Am Acad Dermatol; 2001 Aug; 45(2):208-16. PubMed ID: 11464181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paucity of intraepidermal FoxP3-positive T cells in cutaneous T-cell lymphoma in contrast with spongiotic and lichenoid dermatitis.
    Wada DA; Wilcox RA; Weenig RH; Gibson LE
    J Cutan Pathol; 2010 May; 37(5):535-41. PubMed ID: 19674197
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.